Alpha 2.0
Login Register
» Authors » Alexandra Butzmann

Alexandra Butzmann

Explore the profile of Alexandra Butzmann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 100
Followers 0
Related Specialties
Pathology
Oncology
Hematology
Top 10 Co-Authors
Robert S Ohgami
Jyoti Kumar
Diwash Jangam
Sumanth Gollapudi
Kaushik Sridhar
Roger Warnke
Kunwar Singh
Amol Singh
Roger A Warnke
Robert Shigeo Ohgami
Published In
Int J Lab Hematol
Front Oncol
Curr Eye Res
Int J Mol Med
Arch Pathol Lab Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Smoking status in acute myeloid leukemia is associated with worse overall survival and independent of prior nonhematopoietic malignancies, cytogenetic abnormalities, and WHO category
Kumar J, Patel S, Chang A, Mukherjee S, Small C, Gollapudi S, et al.
Hum Pathol . 2023 Mar; 135:45-53. PMID: 36921727
Acute myeloid leukemia (AML) is an aggressive hematopoietic malignancy with several patient- and disease-associated variables known to impact prognosis. Tobacco smoking is an environmental factor associated with a greater incidence...
2.
Copy Number Loss at Chromosome 14q11.2 Correlates With the Proportion of T Cells in Biopsies and Helps Identify T-Cell Neoplasms
Saglam A, Singh K, Kumar J, Gollapudi S, Mukherjee S, Singh A, et al.
Arch Pathol Lab Med . 2022 Nov; 147(8):940-948. PMID: 36445717
Context.—: Evidence of T-cell clonality is often critical in supporting the diagnosis of a T-cell lymphoma. Objectives.—: To retrospectively explore the significance of copy number losses at the 14q11.2 T-cell...
3.
Indolent T-lymphoblastic proliferation: A systematic review of the literature analyzing the epidemiologic, clinical, and pathologic features of 45 cases
Saglam A, Singh K, Gollapudi S, Kumar J, Brar N, Butzmann A, et al.
Int J Lab Hematol . 2022 May; 44(4):700-711. PMID: 35577551
An indolent T-lymphoblastic proliferation (iT-LBP) is a rare benign disorder characterized by an abnormal expansion of immature T-cells, which morphologically can mimic malignancy. Since the first case was described in...
4.
Case Report: Castleman Disease With an Associated Stromal Spindle Cell Proliferation, Mutation and p53 Expression: Clonal Origins of a Rare Disease
Singh K, Gollapudi S, Kumar J, Butzmann A, Small C, Kreimer S, et al.
Front Oncol . 2022 May; 12:857606. PMID: 35494027
Castleman disease (CD) is a rare lymphoproliferative disorder with distinct clinical subtypes. However, our understanding of the underlying pathogenesis of particular subtypes of CD remains unclear. While the characteristic morphologic...
5.
Mutations in and Genes Are Enriched in Post-Transplant Lymphoproliferative Disorders
Butzmann A, Sridhar K, Jangam D, Song H, Singh A, Kumar J, et al.
Front Oncol . 2022 Feb; 11:790481. PMID: 35111674
Post-transplant lymphoproliferative disorders (PTLD) are diseases occurring in immunocompromised patients after hematopoietic stem cell transplantation (HCT) or solid organ transplantation (SOT). Although PTLD occurs rarely, it may be associated with...
6.
A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease
Butzmann A, Kumar J, Sridhar K, Gollapudi S, Ohgami R
Biology (Basel) . 2021 Apr; 10(4). PMID: 33804823
Castleman disease (CD) is a rare lymphoproliferative disorder known to represent at least four distinct clinicopathologic subtypes. Large advancements in our clinical and histopathologic description of these diverse diseases have...
7.
A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity
Singh K, Mittal S, Gollapudi S, Butzmann A, Kumar J, Ohgami R
Int J Lab Hematol . 2020 Oct; 43(2):324-328. PMID: 33010111
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), known to be the causative agent of COVID-19, has led to a worldwide pandemic. At presentation, individual clinical laboratory blood values, such...
8.
A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis
Butzmann A, Sridhar K, Jangam D, Kumar J, Sahoo M, Shahmarvand N, et al.
Int J Mol Med . 2020 Sep; 46(4):1466-1476. PMID: 32945366
Angioimmunoblastic T‑cell lymphoma (AITL) is a uniquely aggressive mature T‑cell neoplasm. In recent years, recurrent genetic mutations in ras homolog family member A (RHOA), tet methylcytosine dioxygenase 2 (TET2), DNA...
9.
LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations
Brar N, Butzmann A, Kumar J, Peerani R, Morgan E, Grigoriadis G, et al.
Histopathology . 2020 Jun; 77(6):984-988. PMID: 32526041
Aims: An indolent T-lymphoblastic proliferation (iT-LBP) is a benign, reactive expansion of immature terminal deoxynucleotidyl transferase (TdT)-positive T cells found in extrathymic tissues. iT-LBP can be challenging to distinguish from...
10.
Significance of bacterial and viral genotypes as a risk factor in driving cancer (Review)
Jangam D, Butzmann A, Sridhar K, Deresinski S, Banaei N, Ohgami R
Mol Clin Oncol . 2020 Jun; 13(1):3-12. PMID: 32499911
Microbes have been known to drive human cancers for over half a century. However, despite the association of bacterial and viral infections with a high risk of cancer, most infections...